{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T17:45:15Z","timestamp":1781113515278,"version":"3.54.1"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Programa Gilead G\u00c9NESE","award":["PGG\/046\/2015"],"award-info":[{"award-number":["PGG\/046\/2015"]}]},{"name":"Programa Gilead G\u00c9NESE","award":["PGG\/002\/2016"],"award-info":[{"award-number":["PGG\/002\/2016"]}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["COMPETE 2020"],"award-info":[{"award-number":["COMPETE 2020"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"Fundo Europeu de Desenvolvimento Regional","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FCT"},{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FCT","award":["SFRH\/BPD\/92934\/2013"],"award-info":[{"award-number":["SFRH\/BPD\/92934\/2013"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jconrel.2017.09.030","type":"journal-article","created":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T12:47:31Z","timestamp":1506170851000},"page":"119-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Targeted microbicides for preventing sexual HIV transmission"],"prefix":"10.1016","volume":"266","author":[{"given":"Catarina","family":"Coutinho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2317-2759","authenticated-orcid":false,"given":"Jos\u00e9","family":"das Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2016","key":"10.1016\/j.jconrel.2017.09.030_bb0005","first-page":"e361","article-title":"Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980\u20132015: the Global Burden of Disease Study 2015","volume":"3","author":"GBD 2015 HIV Collaborators","year":"2015","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0010","series-title":"AIDS Data","author":"UNAIDS","year":"2016"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0015","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/QAD.0b013e328354622a","article-title":"The evolving epidemiology of HIV\/AIDS","volume":"26","author":"De Cock","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0020","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/hiv.12421","article-title":"Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis","volume":"18","author":"Teeraananchai","year":"2017","journal-title":"HIV Med."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0025","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1016\/S2352-3018(16)30038-8","article-title":"Interventions to strengthen the HIV prevention cascade: a systematic review of reviews","volume":"3","author":"Krishnaratne","year":"2016","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0030","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-med-050911-163701","article-title":"Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxis","volume":"64","author":"Baeten","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0035","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","article-title":"Use of a vaginal ring containing dapivirine for HIV-1 prevention in women","volume":"375","author":"Baeten","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0040","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","article-title":"Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women","volume":"375","author":"Nel","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.addr.2015.12.015","article-title":"Will dapivirine redeem the promises of anti-HIV microbicides? Overview of product design and clinical testing","volume":"103","author":"das Neves","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0050","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1097\/QAD.0b013e3282ef83fd","article-title":"Vaginal microbicides: moving ahead after an unexpected setback","volume":"21","author":"van de Wijgert","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0055","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1089\/aid.2013.0122","article-title":"Pharmacokinetics and pharmacodynamics in HIV prevention; current status and future directions: a summary of the DAIDS and BMGF sponsored think tank on pharmacokinetics (PK)\/pharmacodynamics (PD) in HIV prevention","volume":"29","author":"Romano","year":"2013","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0060","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.bpobgyn.2012.01.004","article-title":"Formulation, pharmacokinetics and pharmacodynamics of topical microbicides","volume":"26","author":"Adams","year":"2012","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","article-title":"Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology","volume":"66","author":"Bertrand","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.addr.2014.08.002","article-title":"Targeted nanotechnology for cancer imaging","volume":"76","author":"Toy","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0075","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.nantod.2014.06.003","article-title":"Nanomedicine in the management of microbial infection - overview and perspectives","volume":"9","author":"Zhu","year":"2014","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0080","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1773-2247(13)50055-4","article-title":"Mucosal drug delivery: barriers, in vitro models and formulation strategies","volume":"23","author":"Boegh","year":"2013","journal-title":"J. Drug Deliv. Sci. Tech."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0085","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/157016212799304599","article-title":"Formulation and delivery of microbicides","volume":"10","author":"Agashe","year":"2012","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0090","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jconrel.2015.08.018","article-title":"Drug transporters in tissues and cells relevant to sexual transmission of HIV: implications for drug delivery","volume":"219","author":"Hu","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.addr.2016.01.017","article-title":"Nanomedicine in the development of anti-HIV microbicides","volume":"103","author":"das Neves","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0100","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bcp.2013.08.013","article-title":"Dissimilarities in the metabolism of antiretroviral drugs used in HIV pre-exposure prophylaxis in colon and vagina tissues","volume":"86","author":"E.E. To","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0105","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/01.aids.0000232230.96134.80","article-title":"Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides","volume":"20","author":"Fletcher","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0110","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1128\/AAC.01129-06","article-title":"Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture","volume":"51","author":"Cummins","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0115","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0140-6736(14)60164-1","article-title":"HIV infection: epidemiology, pathogenesis, treatment, and prevention","volume":"384","author":"Maartens","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0120","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jconrel.2014.08.003","article-title":"Targeting strategies for delivery of anti-HIV drugs","volume":"192","author":"Ramana","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0125","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.addr.2009.11.021","article-title":"Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs","volume":"62","author":"Gunaseelan","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0130","first-page":"1757","article-title":"Nanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous system","volume":"9","author":"Gomes","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0135","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.addr.2016.02.010","article-title":"Role of nanotechnology in HIV\/AIDS vaccine development","volume":"103","author":"Liu","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0140","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006866","article-title":"HIV: cell binding and entry","volume":"2","author":"Wilen","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1600-0897.2010.00939.x","article-title":"Early HIV-1 target cells in human vaginal and ectocervical mucosa","volume":"65","author":"Shen","year":"2011","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0150","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1462-5822.2012.01812.x","article-title":"The molecular basis of HIV entry","volume":"14","author":"Klasse","year":"2012","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0155","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.antiviral.2013.03.017","article-title":"Entry inhibitors and their use in the treatment of HIV-1 infection","volume":"98","author":"Haqqani","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0160","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.antiviral.2009.08.003","article-title":"Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes","volume":"84","author":"Clayton","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0165","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nbt1101","article-title":"Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors","volume":"23","author":"Song","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0170","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/mt.2008.92","article-title":"Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy","volume":"16","author":"Zhou","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0175","doi-asserted-by":"crossref","first-page":"66ra66","DOI":"10.1126\/scitranslmed.3001581","article-title":"An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice","volume":"3","author":"Neff","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0180","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/QAI.0b013e3182653c1f","article-title":"Enhanced anti-HIV efficacy of indinavir after inclusion in CD4-targeted lipid nanoparticles","volume":"61","author":"Endsley","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0185","series-title":"HIV and the Pathogenesis of AIDS","author":"Levy","year":"2007"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0190","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/QAD.0b013e32833424c8","article-title":"Targeting trojan horse leukocytes for HIV prevention","volume":"24","author":"Anderson","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0195","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.progpolymsci.2014.07.010","article-title":"Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: a review","volume":"39","author":"Sosnik","year":"2014","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0200","doi-asserted-by":"crossref","first-page":"e21547","DOI":"10.1371\/journal.pone.0021547","article-title":"Mucoadhesive nanoparticles may disrupt the protective human mucus barrier by altering its microstructure","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0205","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/wnan.144","article-title":"Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?","volume":"3","author":"das Neves","year":"2011","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0210","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ejpb.2015.01.022","article-title":"Nano-carrier systems: strategies to overcome the mucus gel barrier","volume":"96","author":"D\u00fcnnhaupt","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0215","doi-asserted-by":"crossref","first-page":"11388","DOI":"10.1128\/JVI.01377-13","article-title":"Defining the interaction of HIV-1 with the mucosal barriers of the female reproductive tract","volume":"87","author":"Carias","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0220","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature08757","article-title":"Targeting early infection to prevent HIV-1 mucosal transmission","volume":"464","author":"Haase","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0225","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.immuni.2007.01.007","article-title":"Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1","volume":"26","author":"Hladik","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0230","doi-asserted-by":"crossref","first-page":"e1923","DOI":"10.1002\/rmv.1923","article-title":"Langerhans cells and sexual transmission of HIV and HSV","volume":"27","author":"Botting","year":"2017","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0235","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0802203105","article-title":"Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection","volume":"105","author":"Keele","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0240","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nri1960","article-title":"Dendritic-cell interactions with HIV: infection and viral dissemination","volume":"6","author":"Wu","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0245","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nri1182","article-title":"DC-SIGN: escape mechanism for pathogens","volume":"3","author":"van Kooyk","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0250","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(00)80694-7","article-title":"DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells","volume":"100","author":"Geijtenbeek","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0255","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/aji.12409","article-title":"Effect of mucosal cytokine administration on selective expansion of vaginal dendritic cells to support nanoparticle transport","volume":"74","author":"Ramanathan","year":"2015","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0260","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.nano.2017.04.012","article-title":"Chitosan enhances nanoparticle delivery from the reproductive tract to target draining lymphoid organs","volume":"13","author":"Park","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0265","series-title":"Drug Delivery","first-page":"3","article-title":"Passive and active drug targeting: drug delivery to tumors as an example","author":"Torchilin","year":"2010"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0270","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jconrel.2010.11.019","article-title":"Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages","volume":"150","author":"Nowacek","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0275","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/bit.21958","article-title":"A model predicting delivery of saquinavir in nanoparticles to human monocyte\/macrophage (Mo\/Mac) cells","volume":"101","author":"Ece Gamsiz","year":"2008","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0280","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jps.21406","article-title":"Zidovudine-loaded PLA and PLA-PEG blend nanoparticles: influence of polymer type on phagocytic uptake by polymorphonuclear cells","volume":"98","author":"Mainardes","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0285","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1517\/17425247.2011.586334","article-title":"Mucoadhesive nanomedicines: characterization and modulation of mucoadhesion at the nanoscale","volume":"8","author":"das Neves","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0290","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2217\/nnm.13.136","article-title":"Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV prevention","volume":"9","author":"Meng","year":"2014","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0295","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejps.2011.06.007","article-title":"Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion","volume":"44","author":"Meng","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0300","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1021\/acsnano.5b03876","article-title":"Impact of surface polyethylene glycol (PEG) density on biodegradable nanoparticle transport in mucus ex vivo and distribution in vivo","volume":"9","author":"Xu","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0305","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fphys.2016.00579","article-title":"A mouse intra-intestinal infusion model and its application to the study of nanoparticle distribution","volume":"7","author":"Sadio","year":"2016","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0310","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2014.10.026","article-title":"Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse","volume":"197","author":"Maisel","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0315","series-title":"Drug Delivery and Development of Anti-HIV Microbicides","first-page":"415","article-title":"Nanotechnology-based systems for microbicide development","author":"Nunes","year":"2014"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0320","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1007\/s11095-011-0622-3","article-title":"Polymeric nanoparticles affect the intracellular delivery, antiretroviral activity and cytotoxicity of the microbicide drug candidate dapivirine","volume":"29","author":"das Neves","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0325","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1021\/mp4002365","article-title":"In vitro and ex vivo evaluation of polymeric nanoparticles for vaginal and rectal delivery of the anti-HIV drug dapivirine","volume":"10","author":"das Neves","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0330","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.actbio.2015.02.007","article-title":"Precise engineering of dapivirine-loaded nanoparticles for the development of anti-HIV vaginal microbicides","volume":"18","author":"das Neves","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0335","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s11095-008-9765-2","article-title":"Targeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles","volume":"26","author":"Ham","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0340","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nri2801","article-title":"Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design","volume":"10","author":"Zolla-Pazner","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0345","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/(SICI)1096-9071(199812)56:4<327::AID-JMV7>3.0.CO;2-A","article-title":"Concanavalin A-immobilized polystyrene nanospheres capture HIV-1 virions and gp120: potential approach towards prevention of viral transmission","volume":"56","author":"Hayakawa","year":"1998","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0350","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1016\/j.bmcl.2010.03.079","article-title":"Gold nanoparticles capped with sulfate-ended ligands as anti-HIV agents","volume":"20","author":"Di Gianvincenzo","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0355","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1477-3155-8-15","article-title":"PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture","volume":"8","author":"Lara","year":"2010","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-3155-8-1","article-title":"Mode of antiviral action of silver nanoparticles against HIV-1","volume":"8","author":"Lara","year":"2010","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0365","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1039\/C1NJ20396G","article-title":"Dendrimers as topical microbicides with activity against HIV","volume":"36","author":"Jim\u00e9nez","year":"2012","journal-title":"New J. Chem."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0370","doi-asserted-by":"crossref","first-page":"18628","DOI":"10.1039\/C5NR04632G","article-title":"The SPL7013 dendrimer destabilizes the HIV-1 gp120-CD4 complex","volume":"7","author":"Nandy","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0375","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.antiviral.2011.03.186","article-title":"Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1","volume":"90","author":"Telwatte","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0380","doi-asserted-by":"crossref","first-page":"e12309","DOI":"10.1371\/journal.pone.0012309","article-title":"Structure activity relationship of dendrimer microbicides with dual action antiviral activity","volume":"5","author":"Tyssen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0385","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/aid.2005.21.207","article-title":"SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in macaques","volume":"21","author":"Jiang","year":"2005","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0390","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1128\/AAC.50.5.1696-1700.2006","article-title":"Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model","volume":"50","author":"Patton","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0395","doi-asserted-by":"crossref","first-page":"e16258","DOI":"10.1371\/journal.pone.0016258","article-title":"A phase I randomized placebo controlled trial of the safety of 3% SPL7013 Gel (VivaGel(R)) in healthy young women administered twice daily for 14 days","volume":"6","author":"Cohen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0400","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/QAI.0b013e31823f2aeb","article-title":"Measurement of mucosal biomarkers in a phase 1 trial of intravaginal 3% StarPharma LTD 7013 gel (VivaGel) to assess expanded safety","volume":"59","author":"Moscicki","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0405","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jconrel.2012.04.050","article-title":"Carbosilane dendrimer nanotechnology outlines of the broad HIV blocker profile","volume":"161","author":"Chonco","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0410","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.nano.2015.04.013","article-title":"Prevention vaginally of HIV-1 transmission in humanized BLT mice and mode of antiviral action of polyanionic carbosilane dendrimer G2-S16","volume":"11","author":"Sep\u00falveda-Crespo","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0415","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature11544","article-title":"Broad and potent neutralization of HIV-1 by a gp41-specific human antibody","volume":"491","author":"Huang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0420","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bmc.2015.12.003","article-title":"Design, synthesis and activity evaluation of novel peptide fusion inhibitors targeting HIV-1 gp41","volume":"24","author":"Tan","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0425","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/138161207779313722","article-title":"HIV entry inhibitors targeting gp41: from polypeptides to small-molecule compounds","volume":"13","author":"Liu","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0430","series-title":"Nanoparticulate-based contraceptive\/anti-HIV composition and methods","author":"Wickline","year":"2012"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0435","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3851\/IMP2346","article-title":"Cytolytic nanoparticles attenuate HIV-1 infectivity","volume":"18","author":"Hood","year":"2013","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0440","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1182\/blood-2008-05-078154","article-title":"CD4 T cells: fates, functions, and faults","volume":"112","author":"Zhu","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0445","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1172\/JCI45876","article-title":"Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras","volume":"121","author":"Wheeler","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0450","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1093\/nar\/26.17.3915","article-title":"Staining of cell surface human CD4 with 2\u2032-F-pyrimidine-containing RNA aptamers for flow cytometry","volume":"26","author":"Davis","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0455","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/mt.2013.77","article-title":"Durable knockdown and protection from HIV transmission in humanized mice treated with gel-formulated CD4 aptamer-siRNA chimeras","volume":"21","author":"Wheeler","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0460","first-page":"2847","article-title":"Novel intravaginal nanomedicine for the targeted delivery of saquinavir to CD4+ immune cells","volume":"8","author":"Yang","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0465","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1084\/jem.20090378","article-title":"Genetic identity, biological phenotype, and evolutionary pathways of transmitted\/founder viruses in acute and early HIV-1 infection","volume":"206","author":"Salazar-Gonzalez","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0470","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1189\/jlb.1105633","article-title":"Chemokines, chemokine receptors, and cancer metastasis","volume":"79","author":"Kakinuma","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0475","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3390\/v2020574","article-title":"CCR5: from natural resistance to a new anti-HIV strategy","volume":"2","author":"Lopalco","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0480","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev.med.59.061206.112737","article-title":"Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission","volume":"59","author":"Klasse","year":"2008","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0485","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.chembiol.2015.01.005","article-title":"Cell-specific RNA aptamer against human CCR5 specifically targets HIV-1 susceptible cells and inhibits HIV-1 infectivity","volume":"22","author":"Zhou","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0490","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ejpb.2014.06.020","article-title":"Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticles","volume":"88","author":"Chittasupho","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0495","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.colsurfb.2015.05.030","article-title":"LFC131 peptide-conjugated polymeric nanoparticles for the effective delivery of docetaxel in CXCR4 overexpressed lung cancer cells","volume":"133","author":"Wang","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0500","doi-asserted-by":"crossref","first-page":"9874","DOI":"10.1002\/chem.200900923","article-title":"Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN","volume":"15","author":"Mart\u00ednez-\u00c1vila","year":"2009","journal-title":"Chemistry"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0505","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/cbic.200900294","article-title":"Multivalent manno-glyconanoparticles inhibit DC-SIGN-mediated HIV-1 trans-infection of human T cells","volume":"10","author":"Mart\u00ednez-\u00c1vila","year":"2009","journal-title":"Chembiochem"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0510","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/intimm\/dxs115","article-title":"Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells","volume":"25","author":"Garcia-Vallejo","year":"2013","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0515","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3390\/v6020391","article-title":"Pseudo-mannosylated DC-SIGN ligands as potential adjuvants for HIV vaccines","volume":"6","author":"Berzi","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0520","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/j.biomaterials.2014.01.014","article-title":"A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus","volume":"35","author":"Varga","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0525","doi-asserted-by":"crossref","first-page":"13916","DOI":"10.1128\/JVI.01585-07","article-title":"Adhesion molecule interactions facilitate human immunodeficiency virus type 1-induced virological synapse formation between T cells","volume":"81","author":"Jolly","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0530","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/mt.2009.271","article-title":"RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice","volume":"18","author":"Kim","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0535","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1046\/j.1365-2362.2001.00895.x","article-title":"Interactions between major histocompatibility complex class II surface expression and HIV: implications for pathogenesis","volume":"31","author":"Kamp","year":"2001","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0540","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1097\/00002030-200011100-00006","article-title":"Targeting cell-free HIV and virally-infected cells with anti-HLA-DR immunoliposomes containing amphotericin B","volume":"14","author":"Bestman-Smith","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0545","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0005-2736(01)00432-1","article-title":"Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes","volume":"1558","author":"Gagn\u00e9","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0550","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1021\/acs.molpharmaceut.5b00073","article-title":"Biodegradable film for the targeted delivery of siRNA-loaded nanoparticles to vaginal immune cells","volume":"12","author":"Gu","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.030_bb0555","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jconrel.2016.09.020","article-title":"Nanoparticles-in-film for the combined vaginal delivery of anti-HIV microbicide drugs","volume":"243","author":"Cunha-Reis","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.030_bb0560","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jconrel.2014.09.013","article-title":"Formulation and delivery of anti-HIV rectal microbicides: advances and challenges","volume":"194","author":"Nunes","year":"2014","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917308635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917308635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T05:28:05Z","timestamp":1535347685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917308635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":112,"alternative-id":["S0168365917308635"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.09.030","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted microbicides for preventing sexual HIV transmission","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}